332 related articles for article (PubMed ID: 18957965)
1. A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells.
Crombez L; Aldrian-Herrada G; Konate K; Nguyen QN; McMaster GK; Brasseur R; Heitz F; Divita G
Mol Ther; 2009 Jan; 17(1):95-103. PubMed ID: 18957965
[TBL] [Abstract][Full Text] [Related]
2. Insight into the cellular uptake mechanism of a secondary amphipathic cell-penetrating peptide for siRNA delivery.
Konate K; Crombez L; Deshayes S; Decaffmeyer M; Thomas A; Brasseur R; Aldrian G; Heitz F; Divita G
Biochemistry; 2010 Apr; 49(16):3393-402. PubMed ID: 20302329
[TBL] [Abstract][Full Text] [Related]
3. Optimisation of vectorisation property: A comparative study for a secondary amphipathic peptide.
Konate K; Lindberg MF; Vaissiere A; Jourdan C; Aldrian G; Margeat E; Deshayes S; Boisguerin P
Int J Pharm; 2016 Jul; 509(1-2):71-84. PubMed ID: 27224007
[TBL] [Abstract][Full Text] [Related]
4. Everything you always wanted to know about CADY-mediated siRNA delivery* (* but afraid to ask).
Konate K; Rydstrom A; Divita G; Deshayes S
Curr Pharm Des; 2013; 19(16):2869-77. PubMed ID: 23140452
[TBL] [Abstract][Full Text] [Related]
5. A non-covalent peptide-based strategy for siRNA delivery.
Crombez L; Divita G
Methods Mol Biol; 2011; 683():349-60. PubMed ID: 21053142
[TBL] [Abstract][Full Text] [Related]
6. Modeling of non-covalent complexes of the cell-penetrating peptide CADY and its siRNA cargo.
Crowet JM; Lins L; Deshayes S; Divita G; Morris M; Brasseur R; Thomas A
Biochim Biophys Acta; 2013 Feb; 1828(2):499-509. PubMed ID: 23000699
[TBL] [Abstract][Full Text] [Related]
7. Direct translocation as major cellular uptake for CADY self-assembling peptide-based nanoparticles.
Rydström A; Deshayes S; Konate K; Crombez L; Padari K; Boukhaddaoui H; Aldrian G; Pooga M; Divita G
PLoS One; 2011; 6(10):e25924. PubMed ID: 21998722
[TBL] [Abstract][Full Text] [Related]
8. PEP and CADY-mediated delivery of fluorescent peptides and proteins into living cells.
Kurzawa L; Pellerano M; Morris MC
Biochim Biophys Acta; 2010 Dec; 1798(12):2274-85. PubMed ID: 20188697
[TBL] [Abstract][Full Text] [Related]
9. siRNA delivery using amphipathic cell-penetrating peptides into human hepatoma cells.
Furukawa K; Tanaka M; Oba M
Bioorg Med Chem; 2020 Apr; 28(8):115402. PubMed ID: 32146061
[TBL] [Abstract][Full Text] [Related]
10. Design and characterization of a new peptide vector for short interfering RNA delivery.
Chen B; Xu W; Pan R; Chen P
J Nanobiotechnology; 2015 Jun; 13():39. PubMed ID: 26054932
[TBL] [Abstract][Full Text] [Related]
11. A retro-inverso cell-penetrating peptide for siRNA delivery.
Vaissière A; Aldrian G; Konate K; Lindberg MF; Jourdan C; Telmar A; Seisel Q; Fernandez F; Viguier V; Genevois C; Couillaud F; Boisguerin P; Deshayes S
J Nanobiotechnology; 2017 Apr; 15(1):34. PubMed ID: 28454579
[TBL] [Abstract][Full Text] [Related]
12. Impact of Peptide Sequence on Functional siRNA Delivery and Gene Knockdown with Cyclic Amphipathic Peptide Delivery Agents.
Jagrosse ML; Baliga UK; Jones CW; Russell JJ; García CI; Najar RA; Rahman A; Dean DA; Nilsson BL
Mol Pharm; 2023 Dec; 20(12):6090-6103. PubMed ID: 37963105
[TBL] [Abstract][Full Text] [Related]
13. An Amphipathic Structure of a Dipropylglycine-Containing Helical Peptide with Sufficient Length Enables Safe and Effective Intracellular siRNA Delivery.
Oba M; Shibuya M; Yamaberi Y; Yokoo H; Uchida S; Ueda A; Tanaka M
Chem Pharm Bull (Tokyo); 2023; 71(3):250-256. PubMed ID: 36858531
[TBL] [Abstract][Full Text] [Related]
14. Interactions of amphipathic CPPs with model membranes.
Deshayes S; Konate K; Aldrian G; Heitz F; Divita G
Methods Mol Biol; 2011; 683():41-56. PubMed ID: 21053121
[TBL] [Abstract][Full Text] [Related]
15. A non-covalent peptide-based strategy for siRNA delivery.
Crombez L; Charnet A; Morris MC; Aldrian-Herrada G; Heitz F; Divita G
Biochem Soc Trans; 2007 Feb; 35(Pt 1):44-6. PubMed ID: 17233597
[TBL] [Abstract][Full Text] [Related]
16. Structural polymorphism of non-covalent peptide-based delivery systems: highway to cellular uptake.
Deshayes S; Konate K; Aldrian G; Crombez L; Heitz F; Divita G
Biochim Biophys Acta; 2010 Dec; 1798(12):2304-14. PubMed ID: 20541523
[TBL] [Abstract][Full Text] [Related]
17. Histidine-rich cationic amphipathic peptides for plasmid DNA and siRNA delivery.
Kichler A; Mason AJ; Marquette A; Bechinger B
Methods Mol Biol; 2013; 948():85-103. PubMed ID: 23070765
[TBL] [Abstract][Full Text] [Related]
18. Modification of KL4 Peptide Revealed the Importance of Alpha-Helical Structure for Efficient siRNA Delivery.
Qiu Y; Lo JCK; Kwok KCW; Mason AJ; Lam JKW
Nucleic Acid Ther; 2021 Jun; 31(3):220-228. PubMed ID: 32352853
[TBL] [Abstract][Full Text] [Related]
19. Modification of a designed amphipathic cell-penetrating peptide and its effect on solubility, secondary structure, and uptake efficiency.
Jafari M; Karunaratne DN; Sweeting CM; Chen P
Biochemistry; 2013 May; 52(20):3428-35. PubMed ID: 23614788
[TBL] [Abstract][Full Text] [Related]
20. Insight into the role of physicochemical parameters in a novel series of amphipathic peptides for efficient DNA delivery.
Sharma R; Shivpuri S; Anand A; Kulshreshtha A; Ganguli M
Mol Pharm; 2013 Jul; 10(7):2588-600. PubMed ID: 23725377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
